Health and Healthcare

Regeneron : REGN

All Regeneron Articles

248 Articles

Chris Lange | Jan 23, 2020 at 1:35 PM EST

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.

Jon C. Ogg | Dec 24, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

Christmas Eve's top analyst upgrades, downgrades and initiations included Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron Pharmaceuticals…

Jon C. Ogg | Dec 8, 2019 at 10:40 AM EST

10 Large-Cap Stocks Up 1000% to 4000% Over the Past Decade

24/7 Wall St. has identified 10 stocks that have risen 1,000% or more since the last trading day of 2009.

Jon C. Ogg | Nov 12, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva…

Jon C. Ogg | Nov 6, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Altice, CenturyLink, Cigna, Disney, Emerson, Foot Locker, Groupon, Lululemon, Nike, State Street and More

Wednesday's top analyst upgrades, downgrades and initiations included Altice USA, CenturyLink, Cigna, Emerson Electric, Foot Locker, Groupon, Lululemon Athletica, Nike,…

Lee Jackson | Aug 27, 2019 at 7:25 AM EDT

Top Baird Health Care and Biotech Picks Have Massive Upside Potential

One sector that has avoided much of the current trade and recession fear turmoil is health care, and especially the…

Jon C. Ogg | Aug 8, 2019 at 1:05 PM EDT

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas,…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Jon C. Ogg | Jun 18, 2019 at 8:54 AM EDT

Top Analyst Upgrades and Downgrades: Array Bio, Bank of America, Oracle, Pinterest, RingCentral, Snap, SunPower, Twilio, Xilinx and More

Stocks were indicated to open higher on Tuesday after a small gain in the Dow and S&P 500 on Monday.…

Jon C. Ogg | Apr 24, 2019 at 12:55 PM EDT

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top…

Chris Lange | Apr 8, 2019 at 11:10 AM EDT

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Alnylam Pharma and Regeneron Pharma shares dipped on Monday despite announcing a collaboration to discover, develop and commercialize new RNA…

Chris Lange | Mar 11, 2019 at 4:14 PM EDT

Great News for Adolescents with Moderate to Severe Atopic Dermatitis

In an incredible move for adolescent patients 12 to 17 years of age, the U.S. Food and Drug Administration (FDA)…

Jon C. Ogg | Jan 4, 2019 at 10:20 AM EST

Top Analyst Upgrades and Downgrades: Bed Bath & Beyond, CBOE, eBay, Etsy, Intel, Netflix, Nokia, Snap, UTC, Vonage and More

The top analyst upgrades, downgrades and initiations seen on Friday included Bed Bath & Beyond, CBOE, eBay, Etsy, Intel, Netflix,…

Lee Jackson | Dec 14, 2018 at 9:14 AM EST

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline,…

Jon C. Ogg | Nov 12, 2018 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Achaogen, Apple, Athenahealth, Crocs, Disney, Finisar, Jabil, Michael Kors, Occidental, Starbucks and More

The included Achaogen, Apple, Athenahealth, Crocs, Finisar, Jabil, Michael Kors, Occidental Petroleum, Starbucks and Walt Disney.

1 … 5 6 7 8 9 … 17

Regeneron : REGN

All Regeneron Articles

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

10 Large-Cap Stocks Up 1000% to 4000% Over the Past Decade

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Top Analyst Upgrades and Downgrades: Altice, CenturyLink, Cigna, Disney, Emerson, Foot Locker, Groupon, Lululemon, Nike, State Street and More

Top Baird Health Care and Biotech Picks Have Massive Upside Potential

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: Array Bio, Bank of America, Oracle, Pinterest, RingCentral, Snap, SunPower, Twilio, Xilinx and More

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Great News for Adolescents with Moderate to Severe Atopic Dermatitis

Top Analyst Upgrades and Downgrades: Bed Bath & Beyond, CBOE, eBay, Etsy, Intel, Netflix, Nokia, Snap, UTC, Vonage and More

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

Top Analyst Upgrades and Downgrades: Achaogen, Apple, Athenahealth, Crocs, Disney, Finisar, Jabil, Michael Kors, Occidental, Starbucks and More

Evercore’s Top Strategist Says the Best Earnings Are Behind Us. He Still Wants You Buy Tech

MARA Holdings Falls 5%, Riot Platforms Sinks 4% as Rates Outweigh a 35,577 Bitcoin Treasury

Uranium ETFs Just Crashed 30 Percent While AI Power Demand Keeps Breaking Records

At 63, His Sick-Pay Checks Kept Coming. After Six Months, Social Security Tax Stopped.

"Please Don't Buy a Mobile Home": George Kamel Warns Idaho Couple Making $2,500 a Month

WSJ Report Sends Memory Stocks Down. SanDisk Down 9%, Micron Down 7%, Western Digital Down 5%

Evercore’s Top Strategist Says the Best Earnings Are Behind Us. He Still Wants You Buy Tech

Regeneron : REGN

All Regeneron Articles

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

10 Large-Cap Stocks Up 1000% to 4000% Over the Past Decade

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Top Analyst Upgrades and Downgrades: Altice, CenturyLink, Cigna, Disney, Emerson, Foot Locker, Groupon, Lululemon, Nike, State Street and More

Top Baird Health Care and Biotech Picks Have Massive Upside Potential

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: Array Bio, Bank of America, Oracle, Pinterest, RingCentral, Snap, SunPower, Twilio, Xilinx and More

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Great News for Adolescents with Moderate to Severe Atopic Dermatitis

Top Analyst Upgrades and Downgrades: Bed Bath & Beyond, CBOE, eBay, Etsy, Intel, Netflix, Nokia, Snap, UTC, Vonage and More

Top Analyst Upgrades and Downgrades: Activision, BioMarin, Ciena, Delta Air, GlaxoSmithKline, Procter & Gamble, Regeneron, Tesla and More

Top Analyst Upgrades and Downgrades: Achaogen, Apple, Athenahealth, Crocs, Disney, Finisar, Jabil, Michael Kors, Occidental, Starbucks and More

Evercore’s Top Strategist Says the Best Earnings Are Behind Us. He Still Wants You Buy Tech

MARA Holdings Falls 5%, Riot Platforms Sinks 4% as Rates Outweigh a 35,577 Bitcoin Treasury

Uranium ETFs Just Crashed 30 Percent While AI Power Demand Keeps Breaking Records

Featured Reads

At 63, His Sick-Pay Checks Kept Coming. After Six Months, Social Security Tax Stopped.

"Please Don't Buy a Mobile Home": George Kamel Warns Idaho Couple Making $2,500 a Month